Home > Drug Search >
  • company_query: Aduro BioTech
  •   > 
Drug Filter
Category:
chemistry (14) biology (24)
Status:
Approved (2) Phase Ⅲ (3) Phase Ⅱ (15) Phase Ⅰ (18)
Clinical Stage:
Pending (6) Active (27) Discontinued (3)
Bio-Type:
Cell therapy (1) Vaccine (17) Recombinant enzyme (1) Recombinant polypeptide (1) Whole antibody (1)
Indication:
Acute coronary syndrome (ACS) (1) Acute myeloid Leukemia (AML) (1) Alcohol dependence (1) Alzheimer's disease (AD) (1) Atherosclerosis (1) Atopic dermatitis (1) Bladder cancer (1) Breast cancer (3) wound (1) HCV infection (1) Lymphoma (1) Melanoma (4) Multiple myeloma (MM) (2) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (2) Non-24-hour sleep-wake disorder (N24HSWD) (1) Ovarian cancer (2) Pancreatic cancer (3) Parkinson's disease (PD) (1) Hypoalphalipoproteinaemia (1) Lipid metabolism disorders (1) Prostate cancer (3) Rheumatoid arthritis (RA) (1) Schizophrenia (1) Dermal scarring (1) Sleep disorder (1) Social withdrawal (1) Solid tumours (2) Chikungunya virus infections (1) Streptococcal infection (1) Visceral leishmaniasis (1) Head and neck cancer (1) Swine flu (1) Hodgkin lymphoma (1) Colorectal cancer (1) Stroke (1) Sickle cell disease (1) Multiple system atrophy (1) Pruritus (1) Glioblastoma (1) Mesothelioma (2) Bacterial infection (1) Liver cancer (1) Thelassemia (1) Shock (1)
Aprv. Year:
2009 (1) 2014 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top